These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 38903526)

  • 1. Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis.
    Cavalcante P; Mantegazza R; Antozzi C
    Front Immunol; 2024; 15():1404191. PubMed ID: 38903526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenia gravis: from autoantibodies to therapy.
    Mantegazza R; Bernasconi P; Cavalcante P
    Curr Opin Neurol; 2018 Oct; 31(5):517-525. PubMed ID: 30156572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.
    Beecher G; Putko BN; Wagner AN; Siddiqi ZA
    Drugs; 2019 Mar; 79(4):353-364. PubMed ID: 30762205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights in the autoimmunity of myasthenia gravis.
    De Baets MH
    Autoimmunity; 2010 Aug; 43(5-6):341-3. PubMed ID: 20380585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An update on myasthenia gravis].
    Martínez Torre S; Gómez Molinero I; Martínez Girón R
    Semergen; 2018; 44(5):351-354. PubMed ID: 29555378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis: the role of complement at the neuromuscular junction.
    Howard JF
    Ann N Y Acad Sci; 2018 Jan; 1412(1):113-128. PubMed ID: 29266249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis: State of the art and new therapeutic strategies.
    Souto EB; Lima B; Campos JR; Martins-Gomes C; Souto SB; Silva AM
    J Neuroimmunol; 2019 Dec; 337():577080. PubMed ID: 31670062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenia gravis. Update on diagnosis and therapy.
    García Estévez DA; Pardo Fernández J
    Med Clin (Barc); 2023 Aug; 161(3):119-127. PubMed ID: 37248131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune mechanisms in myasthenia gravis.
    Cavalcante P; Bernasconi P; Mantegazza R
    Curr Opin Neurol; 2012 Oct; 25(5):621-9. PubMed ID: 22941261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising therapies for the treatment of myasthenia gravis.
    Uysal SP; Morren JA
    Expert Opin Pharmacother; 2024 Mar; 25(4):395-408. PubMed ID: 38523508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc-Receptor Targeted Therapies for the Treatment of
    Keller CW; Pawlitzki M; Wiendl H; Lünemann JD
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071155
    [No Abstract]   [Full Text] [Related]  

  • 12. Myasthenia gravis and the neuromuscular junction.
    Querol L; Illa I
    Curr Opin Neurol; 2013 Oct; 26(5):459-65. PubMed ID: 23945282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.
    Koneczny I; Herbst R
    Cells; 2019 Jul; 8(7):. PubMed ID: 31269763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.
    Lazaridis K; Tzartos SJ
    Front Immunol; 2020; 11():212. PubMed ID: 32117321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and clinical classification of autoimmune myasthenia gravis.
    Berrih-Aknin S; Frenkian-Cuvelier M; Eymard B
    J Autoimmun; 2014; 48-49():143-8. PubMed ID: 24530233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation.
    Le Panse R; Berrih-Aknin S
    Curr Opin Neurol; 2013 Oct; 26(5):569-76. PubMed ID: 23995274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in autoimmune myasthenia gravis management.
    Wang S; Breskovska I; Gandhy S; Punga AR; Guptill JT; Kaminski HJ
    Expert Rev Neurother; 2018 Jul; 18(7):573-588. PubMed ID: 29932785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis-Pathophysiology, diagnosis, and treatment.
    Tannemaat MR; Huijbers MG; Verschuuren JJGM
    Handb Clin Neurol; 2024; 200():283-305. PubMed ID: 38494283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.
    Sommer N; Melms A; Weller M; Dichgans J
    Doc Ophthalmol; 1993; 84(4):309-33. PubMed ID: 8156854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myasthenia gravis].
    Schodrowski J; Seipelt M; Adibi-Sedeh I; Eienbröker C; Tackenberg B
    Internist (Berl); 2016 Apr; 57(4):349-61. PubMed ID: 27000188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.